RecruitingNot Applicable

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

South Korea30 participantsStarted 2025-01-08

Plain-language summary

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with chronic spinal cord injury 6 months after receiving the award
. Patients with confirmed AD due to bladder fullness in previous urodynamic test
. Patients confirmed to have neurological damage level C1-T6, AIS A or B

Exclusion criteria

. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
. Patients who cannot undergo testing due to hemodynamic instability
. Patients who cannot undergo testing due to overt urinary tract infection

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Bladder volume (ml)

Timeframe: Immediately after the test

Trial details

NCT IDNCT06211491

SponsorPusan National University Yangsan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-30

Contact for this trial

Sungchul Huh, Ph.D

055-360-4000 dr.huhsc@gmail.com

View on ClinicalTrials.gov More Spinal Cord Injuries trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with chronic spinal cord injury 6 months after receiving the award
. Patients with confirmed AD due to bladder fullness in previous urodynamic test
. Patients confirmed to have neurological damage level C1-T6, AIS A or B

Exclusion criteria

. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
. Patients who cannot undergo testing due to hemodynamic instability
. Patients who cannot undergo testing due to overt urinary tract infection